Ufd1-Npl4 Recruit Cdc48 for Disassembly of Ubiquitylated CMG Helicase at the End of Chromosome Replication
Overview
Cell Biology
Molecular Biology
Affiliations
Disassembly of the Cdc45-MCM-GINS (CMG) DNA helicase is the key regulated step during DNA replication termination in eukaryotes, involving ubiquitylation of the Mcm7 helicase subunit, leading to a disassembly process that requires the Cdc48 "segregase". Here, we employ a screen to identify partners of budding yeast Cdc48 that are important for disassembly of ubiquitylated CMG helicase at the end of chromosome replication. We demonstrate that the ubiquitin-binding Ufd1-Npl4 complex recruits Cdc48 to ubiquitylated CMG. Ubiquitylation of CMG in yeast cell extracts is dependent upon lysine 29 of Mcm7, which is the only detectable site of ubiquitylation both in vitro and in vivo (though in vivo other sites can be modified when K29 is mutated). Mutation of K29 abrogates in vitro recruitment of Ufd1-Npl4-Cdc48 to the CMG helicase, supporting a model whereby Ufd1-Npl4 recruits Cdc48 to ubiquitylated CMG at the end of chromosome replication, thereby driving the disassembly reaction.
Characterizing replisome disassembly in human cells.
Jones R, Ruiz J, Scaramuzza S, Nath S, Liu C, Henklewska M iScience. 2024; 27(7):110260.
PMID: 39055910 PMC: 11269944. DOI: 10.1016/j.isci.2024.110260.
CMG helicase disassembly is essential and driven by two pathways in budding yeast.
Polo Rivera C, Deegan T, Labib K EMBO J. 2024; 43(18):3818-3845.
PMID: 39039287 PMC: 11405719. DOI: 10.1038/s44318-024-00161-x.
A Decade of Discovery-Eukaryotic Replisome Disassembly at Replication Termination.
Jones R, Reynolds-Winczura A, Gambus A Biology (Basel). 2024; 13(4).
PMID: 38666845 PMC: 11048390. DOI: 10.3390/biology13040233.
Induction of the human gene promoter activity by natural compound ‑resveratrol.
Arakawa J, Kondoh H, Matsushita T, Ogino Y, Asai M, Tanuma S Mol Med Rep. 2024; 29(6).
PMID: 38577929 PMC: 11025027. DOI: 10.3892/mmr.2024.13216.
Implications of ubiquitination and the maintenance of replication fork stability in cancer therapy.
Xia D, Zhu X, Wang Y, Gong P, Su H, Xu X Biosci Rep. 2023; 43(10).
PMID: 37728310 PMC: 10550789. DOI: 10.1042/BSR20222591.